How to Acknowledge Advance-CTR in Research Publications:
|Are you an awardee of an Advance-CTR funding program?||Have you used an Advance-CTR service?||Are you supported by Advance-CTR for your role with a service core?|
NIH Public Access Policy: For research that is directly supported by Advance-CTR, federal law requires that all NIH funded investigators submit an electronic version of their peer-reviewed manuscript to the National Library of Medicine’s PubMed Central upon acceptance for publication (https://publicaccess.nih.gov/policy.htm).
Manuscripts must be submitted to the NIH Manuscript Submission System (NIHMS) within three months of acceptance for publication.
Additionally, it is the policy of Advance-CTR that researchers acknowledge their support from Advance-CTR in all of their research publications, including works unrelated to their Advance-CTR projects.
Advance-CTR Services include:
• Clinical Research Design, Epidemiology and Biostatistics;
• Biomedical Informatics and Cyberinfrastructure Enhancement; and
• Clinical Research Resources and Facilities.
Investigators who use Advance-CTR program resources are required to acknowledge the grant in any resulting research publications.
Faculty who are supported by Advance-CTR must acknowledge the grant in all research publications that are related to their role with the grant.
Publications that are unrelated to the faculty member’s funded role with Advance-CTR may also be acknowledged.
This is encouraged by NIGMS and Advance-CTR, but at the discretion of the researcher or faculty member.
How to acknowledge Advance-CTR and comply with the NIH public access policy:
1. Acknowledge CTR support in each publication on which you are an author using the applicable statement below.
2. Link the publication from PubMed to NIH grant U54GM115677.
3. Submit the manuscript to the NIHMS upon acceptance for inclusion in PubMed Central.
Suggested acknowledgement statements:
For research conducted with direct support from Advance-CTR via awards or services:
The project described was supported by Institutional Development Award Number U54GM115677 from the National Institute of General Medical Sciences of the National Institutes of Health, which funds Advance Clinical and Translational Research (Advance-CTR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
For other research conducted by awardees and for faculty who are partially supported by Advance-CTR:
[INSERT NAME] is partially supported by Institutional Development Award Number U54GM115677 from the National Institute of General Medical Sciences of the National Institutes of Health, which funds Advance Clinical and Translational Research (Advance-CTR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.”
These guidelines reflect NIH policy. Advance-CTR staff will monitor publications to assure adherence with these requirements. Failure to comply with the terms and conditions of the Public Access Policy may result in the placement of special conditions on current awards or preclusion of grantees from obtaining future Advance-CTR funding.
Citing Advance-CTR support in a biosketch:
U54GM115677 Padbury (PI) 07/01/16-04/30/21
RI-Center for Clinical and Translational Science
Advance Clinical and Translational Research is a statewide consortium of universities, hospital systems and non-profit agencies that provides the infrastructure to support, train and educate investigators conducting clinical and translational research